pAAV-CAG-hCA4-miR122
(Plasmid
#244908)
-
PurposeAAV transgene plasmid encoding human CA4 with miR-122 target site
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 244908 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepAAV
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namehuman CA-IV
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2025.04.21.649868 for the bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-CAG-hCA4-miR122 was a gift from Viviana Gradinaru (Addgene plasmid # 244908 ; http://n2t.net/addgene:244908 ; RRID:Addgene_244908) -
For your References section:
AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain. Lin C, Chen X, Hoang JD, Ristic F, Fan Y, Jang S, Chung JHA, Sullivan EE, Gawda T, Kavvathas B, Tran I, Li Y, Steele AD, Shay TF, Gradinaru V. Cell Rep. 2025 Oct 31;44(11):116419. doi: 10.1016/j.celrep.2025.116419. 10.1016/j.celrep.2025.116419 PubMed 41175373